English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Neurocrine Biosciences announces $2.9 billion acquisition of Soleno Therapeutics
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Takeda ends partnership with Denali Therapeutics on dementia drug program
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Citeline reports first decline in pharma R&D pipeline since the 1990s
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Experts discuss strategies to reduce risk in drug development at API webinar
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

JMIR Publications releases article on advances in precision oncology
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Study shows how blind people map surroundings using sound
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Harvard Medical School researchers study exposome's impact on disease risk
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Mayo Clinic researchers develop method to identify proteins triggering immune responses

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones